Iodeto De Potássio Gl Pharma (Potassium Iodide)

Potassium iodide releases stable iodide ions that saturate the thyroid gland’s sodium‑iodide symporter. By flooding the gland with non‑radioactive iodide, it competitively inhibits the uptake of additional iodine, including radioactive isotopes, thereby reducing radiation dose to the thyroid and supporting normal iodine balance.

The appropriate dose is determined by a qualified prescriber based on the specific indication, patient age, weight, and clinical circumstances. Healthcare professionals follow national or international guidelines to decide the exact amount and dosing schedule.

Safety data for potassium iodide in pregnancy and lactation are limited. Use should be discussed with a healthcare provider, who will weigh potential benefits against any possible risks to the mother and infant before recommending treatment.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Potassium iodide is the standard, widely available iodide used for thyroid blocking because it directly supplies stable iodide ions. Alternative agents, such as perchlorate, act by inhibiting iodide uptake but are less commonly used due to safety and regulatory considerations.

Store Iodeto De Potássio Gl Pharma at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, heat and direct sunlight, and ensure the container is tightly closed to maintain stability.

The product is taken orally, typically as a tablet or liquid formulation, as directed by a healthcare professional. It should be swallowed with water and taken according to the prescribed schedule, which may vary depending on the indication.

Serious risks include severe allergic reactions (anaphylaxis), significant thyroid dysfunction (hypo‑ or hyper‑thyroidism), hyperkalemia especially in patients with kidney disease, and rare but severe skin reactions such as Stevens‑Johnson syndrome. Immediate medical attention is required if these occur.

Individuals with known hypersensitivity to potassium iodide, untreated hyperthyroidism, severe renal impairment, or those on medications that may cause dangerous potassium accumulation should avoid using this product unless supervised by a qualified clinician.